Influence of durvalumab consolidation on pneumonitis after chemoradiotherapy for unresectable non-small cell lung cancer

被引：0
|
作者：
Murata, Saori [1 ]
Horinouchi, Hidehito [1 ]
Morishita, Momoko [1 ]
Kaku, Sawako [2 ]
Shinno, Yuki [1 ]
Okuma, Yusuke [1 ]
Yoshida, Tatsuya [1 ,3 ]
Goto, Yasushi [1 ]
Yamamoto, Noboru [1 ,3 ]
Okuma, Kae [4 ]
Kusumoto, Masahiko [2 ]
Ohe, Yuichiro [1 ]
机构：
[1] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan
[2] Natl Canc Ctr, Dept Diag Radiol, Tokyo, Japan
[3] Natl Canc Ctr, Dept Expt Therapeut, Tokyo, Japan
[4] Natl Canc Ctr, Dept Radiat Oncol, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.157
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO3-2
引用
收藏
页码：S1396 / S1396
页数：1
相关论文
共 50 条
  • [1] Pneumonitis and corticosteroid treatment in patients with unresectable non-small cell lung cancer receiving durvalumab consolidation after definitive chemoradiotherapy
    Murata, S.
    Horinouchi, H.
    Morishita, M.
    Kaku, S.
    Shinno, Y.
    Okuma, Y.
    Yoshida, T.
    Goto, Y.
    Yamamoto, N.
    Okuma, K.
    Kusumoto, M.
    Ohe, Y.
    ANNALS OF ONCOLOGY, 2022, 33 : S1555 - S1555
  • [2] Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer
    Edwards, Donna M.
    Sankar, Kamya
    Alseri, Aaren
    Jiang, Ralph
    Schipper, Matthew
    Miller, Sean
    Dess, Kathryn
    Strohbehn, Garth W.
    Moghanaki, Drew
    Ramnath, Nithya
    Green, Michael D.
    Bryant, Alex K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 118 (04): : 963 - 970
  • [3] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    JAMA NETWORK OPEN, 2024, 7 (04) : e247542
  • [4] Multi-Institutional Study of Pneumonitis After Treatment with Durvalumab and Chemoradiotherapy for Non-Small Cell Lung Cancer
    Sita, T.
    Hassanzadeh, C.
    Savoor, R.
    Samson, P.
    Bradley, J.
    Gentile, M.
    Roach, M.
    Mohindra, N.
    Waqar, S.
    Robinson, C.
    Kruser, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1131 - S1132
  • [5] Feasibility of salvage resection following locoregional failure after chemoradiotherapy and consolidation durvalumab for unresectable stage III non-small cell lung cancer
    Dickhoff, C.
    Unal, S.
    Heineman, D. J.
    Winkelman, J. A.
    Braun, J.
    Bahce, I.
    van Dorp, M.
    Senan, S.
    Dahele, M.
    LUNG CANCER, 2023, 182
  • [6] Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
    Tomasini, Pascale
    Greillier, Laurent
    Boyer, Arnaud
    Jeanson, Arnaud
    Barlesi, Fabrice
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1032 - S1036
  • [7] Patterns and Incidence of Pneumonitis and Initial Treatment Outcomes with Durvalumab Consolidation Therapy after Radical Chemoradiotherapy for Stage III Non-Small Cell Lung Cancer
    Sato, Mizuki
    Odagiri, Kazumasa
    Tabuchi, Yuya
    Okamoto, Hiroaki
    Shimokawa, Tsuneo
    Nakamura, Yukiko
    Hata, Masaharu
    CANCERS, 2024, 16 (06)
  • [8] Real world assessment of clinical benefit with consolidation durvalumab following chemoradiotherapy in stage III unresectable non-small cell lung cancer
    Marur, Shanthi
    Mangurian, Mark
    Wise, Corey
    Pozotrigo, Melissa
    Marur, Shika
    Norden, Andrew D.
    Toler, Andrew
    Bobolts, Laura Rose
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Radiation pneumonitis after definitive chemoradiation and durvalumab for non-small cell lung cancer
    Voong, Khinh Ranh
    Naidoo, Jarushka
    LUNG CANCER, 2020, 150 : 249 - 251
  • [10] Inferior Outcomes in Minority Patients with Unresectable Non-Small Cell Lung Cancer (NSCLC) After Durvalumab Consolidation Therapy
    Dickson, F.
    Raez, L.
    Dumais, K.
    Powery, H.
    Walker, D.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S904 - S905
12345